Published in N Engl J Med on April 03, 1986
Prevalence of hibernating myocardium in patients with severely impaired ischaemic left ventricles. Heart (1998) 1.57
Pre-clinical myocardial metabolic alterations in chronic kidney disease. Cardiology (2010) 1.43
Biphasic response to dobutamine predicts improvement of left ventricular dysfunction after revascularization: correlation with positron emission and rest-redistribution 201Tl tomographies. Int J Cardiovasc Imaging (2003) 1.40
FDG imaging should be considered the preferred technique for accurate assessment of myocardial viability: for. Eur J Nucl Med Mol Imaging (2005) 1.39
Cardiovascular molecular imaging: focus on clinical translation. Circulation (2011) 1.24
Methodology governing the assessment of myocardial glucose metabolism by positron emission tomography and fluorine 18-labeled fluorodeoxyglucose. J Nucl Cardiol (1998) 1.16
Recurrent ischemia in the canine heart causes recurrent bursts of free radical production that have a cumulative effect on contractile function. A pathophysiological basis for chronic myocardial "stunning". J Clin Invest (1995) 1.12
Myocardial perfusion and contraction in acute ischemia and chronic ischemic heart disease. J Mol Cell Cardiol (2011) 1.08
Imaging techniques in nuclear cardiology for the assessment of myocardial viability. Int J Cardiovasc Imaging (2005) 0.96
Myocardial ischemia--metabolic pathways and implications of increased glycolysis. Cardiovasc Drugs Ther (1990) 0.95
Prediction of functional recovery after revascularization in patients with chronic ischaemic left ventricular dysfunction: head-to-head comparison between 99mTc-sestamibi/18F-FDG DISA SPECT and 13N-ammonia/ 18F-FDG PET. Eur J Nucl Med Mol Imaging (2006) 0.94
Multimodality imaging in the assessment of myocardial viability. Heart Fail Rev (2011) 0.94
Measuring regional changes in the diastolic deformation of the left ventricle of SHR rats using microPET technology and hyperelastic warping. Ann Biomed Eng (2008) 0.93
Viable myocardium and reinjection of thallium. Br Heart J (1992) 0.91
Imaging myocardial metabolic remodeling. J Nucl Med (2010) 0.91
Efficacy of coronary angioplasty for the treatment of hibernating myocardium. Heart (1999) 0.90
Comparison of wall thickening and ejection fraction by cardiovascular magnetic resonance and echocardiography in acute myocardial infarction. J Cardiovasc Magn Reson (2009) 0.89
Chronic ischemic left ventricular dysfunction: from pathophysiology to imaging and its integration into clinical practice. JACC Cardiovasc Imaging (2008) 0.88
Pharmacology of endothelium-derived nitric oxide and nitrovasodilators. West J Med (1991) 0.88
Glucose metabolism distal to a critical coronary stenosis in a canine model of low-flow myocardial ischemia. J Clin Invest (1996) 0.86
Incidence of hibernating myocardium after acute myocardial infarction treated with thrombolysis. Heart (1996) 0.86
Metabolic imaging using PET. Eur J Nucl Med Mol Imaging (2007) 0.86
Angiography and the aetiology of heart failure. Postgrad Med J (1995) 0.85
Left ventricular dysfunction due to stunning and hibernation in patients. Cardiovasc Drugs Ther (1994) 0.85
Cardiac perfusion imaging using hyperpolarized (13) c urea using flow sensitizing gradients. Magn Reson Med (2015) 0.85
Diagnostic value of (18)F-FDG PET in the assessment of myocardial viability in coronary artery disease: A comparative study with (99m)Tc SPECT and echocardiography. J Geriatr Cardiol (2014) 0.85
Effects of glucose-insulin-potassium infusion on chronic ischaemic left ventricular dysfunction. Heart (2003) 0.84
The potential roles of 18F-FDG-PET in management of acute stroke patients. Biomed Res Int (2013) 0.84
Positron emission tomography and myocardial imaging. Heart (2000) 0.83
Electrocardiographic-gated dual-isotope simultaneous acquisition SPECT using 18F-FDG and 99mTc-sestamibi to assess myocardial viability and function in a single study. Eur J Nucl Med Mol Imaging (2004) 0.83
Clinical assessment of myocardial hibernation. Heart (2005) 0.83
Present and future of clinical cardiovascular PET imaging in Europe--a position statement by the European Council of Nuclear Cardiology (ECNC). Eur J Nucl Med Mol Imaging (2008) 0.83
Pathophysiology of myocardial hibernation. Implications for the use of dobutamine echocardiography to identify myocardial viability. Heart (1999) 0.83
Molecular and cellular basis of viable dysfunctional myocardium. Circ Heart Fail (2014) 0.83
Simultaneous assessment of cardiac metabolism and perfusion using copolarized [1-(13) C]pyruvate and (13) C-urea. Magn Reson Med (2016) 0.82
Quantitative cardiac positron emission tomography: the time is coming! Scientifica (Cairo) (2012) 0.82
Enhanced myocardial fluorodeoxyglucose uptake following Adriamycin-based therapy: Evidence of early chemotherapeutic cardiotoxicity? World J Radiol (2012) 0.82
Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis. Ont Health Technol Assess Ser (2005) 0.82
Diagnostic and imaging considerations: role of viability. Heart Fail Rev (2006) 0.82
Incidence of stunned, hibernating and scarred myocardium in ischaemic cardiomyopathy. Eur J Nucl Med Mol Imaging (2004) 0.82
Comparison of 99mTc-sestamibi/18FDG DISA SPECT with PET for the detection of viability in patients with coronary artery disease and left ventricular dysfunction. Eur J Nucl Med Mol Imaging (2005) 0.81
Detection of scarred and viable myocardium using a new magnetic resonance imaging technique: blood oxygen level dependent (BOLD) MRI. Heart (2003) 0.81
Quantitative analysis of myocardial glucose utilization in patients with left ventricular dysfunction by means of 18F-FDG dynamic positron tomography and three-compartment analysis. Eur J Nucl Med Mol Imaging (2005) 0.81
Alternative Imaging Modalities in Ischemic Heart Failure (AIMI-HF) IMAGE HF Project I-A: study protocol for a randomized controlled trial. Trials (2013) 0.80
Radionuclide techniques for the assessment of myocardial viability. Tex Heart Inst J (1998) 0.80
Myocardial viability. West J Med (1996) 0.79
Targeted metabolic imaging to improve the management of heart disease. JACC Cardiovasc Imaging (2012) 0.79
Attenuation correction in cardiac PET/CT with three different CT protocols: a comparison with conventional PET. Eur J Nucl Med Mol Imaging (2007) 0.79
Positron emission tomography probe demonstrates a striking concentration of ribose salvage in the liver. Proc Natl Acad Sci U S A (2014) 0.79
PET/CT guidance for percutaneous fine needle aspiration cytology/biopsy. Indian J Radiol Imaging (2009) 0.79
New SPECT and PET radiopharmaceuticals for imaging cardiovascular disease. Biomed Res Int (2014) 0.79
Impact of CT attenuation correction on the viability pattern assessed by 99mTc-tetrofosmin SPECT/ 18F-FDG PET. Int J Cardiovasc Imaging (2010) 0.79
Clinical use of quantitative cardiac perfusion PET: rationale, modalities and possible indications. Position paper of the Cardiovascular Committee of the European Association of Nuclear Medicine (EANM). Eur J Nucl Med Mol Imaging (2016) 0.78
Relation between the kinetics of thallium-201 in myocardial scintigraphy and myocardial metabolism in patients with acute myocardial infarction. Heart (1998) 0.78
Cardiac positron emission tomography: myocardial perfusion and metabolism in clinical practice. Clin Res Cardiol (2008) 0.78
Quantitation of the thickness of the non-enhanced myocardial rim predicts recovery of territorial myocardial function in chronic ischemic heart disease: a cardiac magnetic resonance imaging study. Clin Res Cardiol (2010) 0.78
Evidence that stunning can be cumulative in man. Heart Fail Rev (2003) 0.77
Ischaemic memory imaging using metabolic radiopharmaceuticals: overview of clinical settings and ongoing investigations. Eur J Nucl Med Mol Imaging (2013) 0.77
Imaging of myocardial metabolism by positron emission tomography. Cardiovasc Drugs Ther (1990) 0.77
F-18 fluorodeoxyglucose uptake and water-perfusable tissue fraction in assessment of myocardial viability. Ann Nucl Med (2012) 0.77
Impact of preoperative positron emission tomography in patients with severely impaired LV-function undergoing surgical revascularization. Int J Cardiovasc Imaging (2010) 0.77
The role of myocardial viability in contemporary cardiac practice. Heart Fail Rev (2017) 0.77
Late gadolinium enhancement magnetic resonance imaging for the assessment of myocardial infarction: comparison of image quality between single and double doses of contrast agents. Int J Cardiovasc Imaging (2014) 0.77
Is it Feasible to Use the Commercially Available Autoquantitation Software for the Evaluation of Myocardial Viability on Small-Animal Cardiac F-18 FDG PET Scan? Nucl Med Mol Imaging (2013) 0.76
Can the surface electrocardiogram be used to predict myocardial viability? Heart (1999) 0.76
Cardiac ischemia. Part I--Metabolic and physiologic responses. West J Med (1987) 0.76
Relationship between regional 18F-fluorodeoxyglucose and 13N ammonia uptake in normal myocardium assessed by positron emission tomography: patterns of mismatch and effects of aging. Int J Cardiovasc Imaging (2001) 0.75
Long-term prognostic value of stress-redistribution-reinjection Tl-201 imaging in patients with severe left ventricular dysfunction and coronary artery bypass surgery. Int J Cardiovasc Imaging (2002) 0.75
CT imaging of myocardial viability: experimental and clinical evidence. Cardiovasc J Afr (2007) 0.75
Myocardial hibernation, stunning, or both? Basic Res Cardiol (1995) 0.75
Early assessment of myocardial contractility by contrast-enhanced magnetic resonance (ceMRI) imaging after revascularization in acute myocardial infarction (AMI). Korean J Intern Med (2004) 0.75
Quantitative study of cardiac motion estimation and abnormality classification in emission computed tomography. Med Eng Phys (2011) 0.75
Dobutamine echocardiography and myocardial contrast echocardiography. Two new techniques for the assessment of myocardial viability. Tex Heart Inst J (1995) 0.75
Blood flow, flow reserve, and glucose utilization in viable and nonviable myocardium in patients with ischemic cardiomyopathy. Eur J Nucl Med Mol Imaging (2013) 0.75
Reversible congestive heart failure caused by myocardial hibernation. Tex Heart Inst J (1999) 0.75
Imaging oxygen metabolism with hyperpolarized magnetic resonance: a novel approach for cardiac and renal function assessement. Biosci Rep (2016) 0.75
Expression of uncoupling protein-2 remains increased within hibernating myocardium despite successful coronary artery bypass grafting at 4 wk post-revascularization. J Surg Res (2014) 0.75
Nuclear cardiac imaging for the assessment of myocardial viability. Neth Heart J (2005) 0.75
Value of Hybrid Imaging with PET/CT to Guide Percutaneous Revascularization of Chronic Total Coronary Occlusion. Curr Cardiovasc Imaging Rep (2015) 0.75
Severe ischemic cardiomyopathy-a new answer in management? Ann Transl Med (2016) 0.75
Current status of viability assessment with positron tomography. J Nucl Cardiol (1998) 0.75
PET radiopharmaceuticals used in viability studies in acute myocardial infarction: a literature survey. Eur J Nucl Med Mol Imaging (2001) 0.75
Microvascular function, is there a link to myocardial viability: Is this another piece to the puzzle? J Nucl Cardiol (2016) 0.75
Accuracy of 3D acquisition mode for myocardial FDG PET studies using a BGO-based scanner. Eur J Nucl Med Mol Imaging (2007) 0.75
Viable but noncontractile myocardium: the clinical problem. J Nucl Cardiol (1998) 0.75
Imaging modalities for detection of myocardial viability. MAGMA (1998) 0.75
Assessment of left ventricular dysfunction by nuclear cardiology. Cardiovasc Drugs Ther (1994) 0.75
Merits and limitations of radionuclide approaches to viability and future developments. J Nucl Cardiol (1998) 0.75
Coronary artery surgery for ischaemic heart failure: the surgeon's view. Heart Fail Rev (2003) 0.75
The Potential of Clinical Phenotyping of Heart Failure With Imaging Biomarkers for Guiding Therapies: A Focused Update. JACC Cardiovasc Imaging (2017) 0.75
Investigation of myocardial metabolism for the study of the pathophysiology of cardiac disease. J Nucl Cardiol (1998) 0.75
Hypodense regions in unenhanced CT identify nonviable myocardium: validation versus 18F-FDG PET. Eur J Nucl Med Mol Imaging (2012) 0.75
Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Ann Surg (1978) 7.57
Effect of sympathetic reinnervation on cardiac performance after heart transplantation. N Engl J Med (2001) 3.39
Reproducibility of metabolic measurements in malignant tumors using FDG PET. J Nucl Med (1999) 3.20
Noninvasive imaging of alpha(v)beta3 integrin expression using 18F-labeled RGD-containing glycopeptide and positron emission tomography. Cancer Res (2001) 3.01
Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging. J Clin Oncol (2001) 2.91
Safety profile of adenosine stress perfusion imaging: results from the Adenoscan Multicenter Trial Registry. J Am Coll Cardiol (1994) 2.78
Epstein-Barr virus DNA is amplified in transformed lymphocytes. J Virol (1979) 2.78
Nonmyeloablative bone marrow transplantation from partially HLA-mismatched related donors using posttransplantation cyclophosphamide. Biol Blood Marrow Transplant (2002) 2.69
Breast imaging with positron emission tomography and fluorine-18 fluorodeoxyglucose: use and limitations. J Clin Oncol (2000) 2.58
The [18F]fluorodeoxyglucose method for the measurement of local cerebral glucose utilization in man. Circ Res (1979) 2.41
Positron emission tomography using [(18)F]Fluorodeoxyglucose for monitoring primary chemotherapy in breast cancer. J Clin Oncol (2000) 2.28
Angiotensin-converting-enzyme gene insertion/deletion polymorphism and response to physical training. Lancet (1999) 2.27
Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography. J Am Coll Cardiol (1992) 2.18
Effect of carbon-11-acetate recirculation on estimates of myocardial oxygen consumption by PET. J Nucl Med (1991) 2.18
Evaluation of the novel myocardial perfusion positron-emission tomography tracer 18F-BMS-747158-02: comparison to 13N-ammonia and validation with microspheres in a pig model. Circulation (2009) 2.15
Informatics and medicine--from molecules to populations. Methods Inf Med (2008) 2.13
Glucose metabolism of breast cancer assessed by 18F-FDG PET: histologic and immunohistochemical tissue analysis. J Nucl Med (2001) 2.12
Radiolabeled alpha(v)beta3 integrin antagonists: a new class of tracers for tumor targeting. J Nucl Med (1999) 2.11
Noninvasive quantification of regional blood flow in the human heart using N-13 ammonia and dynamic positron emission tomographic imaging. J Am Coll Cardiol (1990) 2.07
Neoadjuvant therapy of esophageal squamous cell carcinoma: response evaluation by positron emission tomography. Ann Surg (2001) 2.04
Glycosylated RGD-containing peptides: tracer for tumor targeting and angiogenesis imaging with improved biokinetics. J Nucl Med (2001) 2.00
Effect of APOE genotype on amyloid plaque load and gray matter volume in Alzheimer disease. Neurology (2009) 1.99
Child pedestrian mortality and traffic volume in New Zealand. BMJ (1992) 1.98
The RNA code and protein synthesis. Cold Spring Harb Symp Quant Biol (1966) 1.96
Comparison of fluorine-18-fluorodeoxyglucose PET, MRI and endoscopy for staging head and neck squamous-cell carcinomas. J Nucl Med (1995) 1.95
Low follicular oestrogen levels in New Zealand women consuming high fibre diets: a risk factor for osteopenia? N Z Med J (1993) 1.93
Fluorine-18-fluorodeoxyglucose positron emission tomography is useless for the detection of local recurrence after radical prostatectomy. Eur Urol (1999) 1.86
Event-related functional magnetic resonance imaging in Parkinson's disease before and after levodopa. Brain (2001) 1.83
The dimensions of DNA in solution. J Mol Biol (1981) 1.80
An evaluation of the relationship between self-report and biochemical measures of environmental tobacco smoke exposure. Prev Med (1994) 1.79
Human gene for physical performance. Nature (1998) 1.78
Afterload reduction with vasodilators and diuretics decreases mitral regurgitation during upright exercise in advanced heart failure. J Am Coll Cardiol (1990) 1.73
Distinct syndromes of hemineglect. Arch Neurol (1992) 1.71
Use of a clinical event monitor to prevent and detect medication errors. Proc AMIA Symp (2000) 1.69
The relationship between myocardial retention of technetium-99m teboroxime and myocardial blood flow. J Am Coll Cardiol (1992) 1.68
Preoperative positron emission tomographic viability assessment and perioperative and postoperative risk in patients with advanced ischemic heart disease. J Am Coll Cardiol (1997) 1.68
Accuracy and feasibility of contrast echocardiography for detection of perfusion defects in routine practice: comparison with wall motion and technetium-99m sestamibi single-photon emission computed tomography. The Nycomed NC100100 Investigators. J Am Coll Cardiol (1998) 1.64
Cerebral activation in patients with irritable bowel syndrome and control subjects during rectosigmoid stimulation. Psychosom Med (2001) 1.64
Synthesis and radiopharmacology of O-(2-[18F]fluoroethyl)-L-tyrosine for tumor imaging. J Nucl Med (1999) 1.63
An outbreak of candidiasis in a special care baby unit: the use of a resistogram typing method. J Hosp Infect (1986) 1.61
Whole-body positron emission tomography in clinical oncology: comparison between attenuation-corrected and uncorrected images. Eur J Nucl Med (1997) 1.61
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Inflammation and mitochondrial fatty acid beta-oxidation link obesity to early tumor promotion. Proc Natl Acad Sci U S A (2009) 1.60
In vitro acetylcholinesterase inhibition by type A botulinum toxin. J Bacteriol (1967) 1.57
Conductivities of three-layer live human skull. Brain Topogr (2002) 1.57
Sleep apnoea related hypoxia is associated with cognitive disturbances in patients with tetraplegia. Spinal Cord (1998) 1.55
Regional myocardial blood flow and metabolism at rest in mildly symptomatic patients with hypertrophic cardiomyopathy. J Am Coll Cardiol (1989) 1.51
O-(2-[18F]fluoroethyl)-L-tyrosine and L-[methyl-11C]methionine uptake in brain tumours: initial results of a comparative study. Eur J Nucl Med (2000) 1.48
Quantitative evaluation of regional substrate metabolism in the human heart by positron emission tomography. J Am Coll Cardiol (1991) 1.48
Relationship between altered sympathetic innervation, oxidative metabolism and contractile function in the cardiomyopathic human heart; a non-invasive study using positron emission tomography. Eur Heart J (2001) 1.47
An area analysis of child injury morbidity in Auckland. J Paediatr Child Health (1992) 1.47
The detection rate of [11C]choline-PET/CT depends on the serum PSA-value in patients with biochemical recurrence of prostate cancer. Eur J Nucl Med Mol Imaging (2007) 1.46
Asexual development of Cryptosporidium parvum within a differentiated human enterocyte cell line. Infect Immun (1991) 1.46
Deleted chromosome 18 with paternal mosaicism. Lancet (1967) 1.45
Metaiodobenzylguanidine scintigraphy of the heart: what have we learnt clinically? Eur J Nucl Med (2000) 1.45
Searches for Lepton flavor violation in the decays tau{+/-}-->e{+/-}gamma and tau{+/-}-->mu{+/-}gamma. Phys Rev Lett (2010) 1.44
Region-specific encoding of sensory and affective components of pain in the human brain: a positron emission tomography correlation analysis. Ann Neurol (1999) 1.43
Sex differences in brain activity during aversive visceral stimulation and its expectation in patients with chronic abdominal pain: a network analysis. Neuroimage (2008) 1.43
Magnetic resonance imaging in intractable partial epilepsy: correlative studies. Ann Neurol (1986) 1.43
Focal metabolic activation in the predominant left auditory cortex in patients suffering from tinnitus: a PET study with [18F]deoxyglucose. ORL J Otorhinolaryngol Relat Spec (1997) 1.42
Quinapril and hydrochlorothiazide combination for control of hypertension: assessment by factorial design. Quinapril Investigator Group. J Hum Hypertens (1994) 1.42
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41
Determination of extent and location of coronary artery disease in patients without prior myocardial infarction by thallium-201 tomography with pharmacologic stress. J Nucl Med (1992) 1.41
Comparison of technetium-99m sestamibi and thallium-201 retention characteristics in canine myocardium. J Am Coll Cardiol (1992) 1.41
Walking index for spinal cord injury (WISCI): an international multicenter validity and reliability study. Spinal Cord (2000) 1.40
The tilt test: effect of diabetes mellitus and antihypertensive medication on normal values. J Emerg Med (1994) 1.39
Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7 TeV. Phys Rev Lett (2011) 1.39
An automated analysis program for the evaluation of cardiac PET studies: initial results in the detection and localization of coronary artery disease using nitrogen-13-ammonia. J Nucl Med (1993) 1.39
Technology for mobility in SCI 10 years from now. Spinal Cord (2012) 1.39
Decline of cerebral glucose metabolism in frontotemporal dementia: a longitudinal 18F-FDG-PET-study. Neurobiol Aging (2006) 1.39
Fatal venous air embolism in a cat undergoing dental extractions. J Small Anim Pract (2008) 1.38
Cerebral correlates of depressed behavior in rats, visualized using 14C-2-deoxyglucose autoradiography. J Neurosci (1988) 1.38
Early recovery of coronary flow reserve after stent implantation as assessed by positron emission tomography. J Am Coll Cardiol (1999) 1.38
Characterization of translocation contact sites involved in the import of mitochondrial proteins. J Cell Biol (1987) 1.37
Validation of nitrogen-13-ammonia tracer kinetic model for quantification of myocardial blood flow using PET. J Nucl Med (1993) 1.36
Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34
CDX1 is an important molecular mediator of Barrett's metaplasia. Proc Natl Acad Sci U S A (2005) 1.34
Cerebral glucose metabolism in patients with AD and different APOE genotypes. Neurology (2005) 1.33
Radiolabelled RGD peptides for imaging and therapy. Eur J Nucl Med Mol Imaging (2012) 1.33
A randomized trial of late reperfusion therapy for acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction-6 Study Group. Circulation (1992) 1.32
Positron emission tomography in non-Hodgkin's lymphoma: assessment of chemotherapy with fluorodeoxyglucose. Blood (1998) 1.32
Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32
In vitro susceptibility of anaerobic bacteria to ciprofloxacin (Bay o 9867). Antimicrob Agents Chemother (1984) 1.31
Simple noninvasive quantification method for measuring myocardial glucose utilization in humans employing positron emission tomography and fluorine-18 deoxyglucose. J Nucl Med (1989) 1.30
The acute respiratory distress syndrome: fibrosis in the fast lane. Thorax (1998) 1.29
Cardiac sympathetic dysinnervation in diabetes: implications for enhanced cardiovascular risk. Circulation (1998) 1.29
Carbon-11-acetate PET imaging in renal disease. J Nucl Med (1995) 1.28
Visual working memory in primary generalized epilepsy: an 18FDG-PET study. Neurology (1996) 1.26
Differential diagnosis of CNS lesions in AIDS patients by FDG-PET. J Comput Assist Tomogr (1995) 1.26
Assessing the accuracy of topographic EEG mapping for determining local brain function. Electroencephalogr Clin Neurophysiol (1998) 1.25
Synthesis and biological evaluation of a (99m)Tc-labelled cyclic RGD peptide for imaging the alphavbeta3 expression. Nuklearmedizin (2004) 1.25
The urban traffic environment and the risk of child pedestrian injury: a case-crossover approach. Epidemiology (1995) 1.23
Attention deficit-hyperactivity disorder and asymmetry of the caudate nucleus. J Child Neurol (1993) 1.23
Gender differences in regional brain response to visceral pressure in IBS patients. Eur J Pain (2000) 1.23
Uptake of radiolabeled 2'-fluoro-2'-deoxy-5-iodo-1-beta-D-arabinofuranosyluracil in cardiac cells after adenoviral transfer of the herpesvirus thymidine kinase gene: the cellular basis for cardiac gene imaging. Circulation (2000) 1.22
Inter-crystal scatter in a dual layer, high resolution LSO-APD positron emission tomograph. Phys Med Biol (2003) 1.22
Is coagulase-negative staphylococcal bacteraemia in neonates a consequence of mechanical ventilation? J Hosp Infect (1984) 1.22